Literature DB >> 11421504

Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease.

S Tassiopoulos1, A Kontos, K Konstantopoulos, C Hadzistavrou, G Vaiopoulos, A Aessopos, T Tassiopoulos.   

Abstract

The aim of this study was to assess the erythropoietic response to hypoxaemia in patients with diffuse idiopathic pulmonary fibrosis (DIPF), and to speculate on the underlying mechanisms. Patients on an established chronic respiratory failure due to DIPF or chronic obstructive pulmonary disease (COPD) were studied. The erythropoietic response to hypoxaemia in both conditions was assessed. We studied 18 patients with DIPF and 29 patients with COPD in respiratory failure in a stable stage, free from acute infection and congestive heart failure. Blood gases, erythrocytic parameters, as well the serum levels of iron, ferritin and erythropoietin were determined. All the DIPF patients studied, apart from two, had normal or subnormal haematocrit values. The patients with COPD had an inconsistant response to hypoxaemia; 12 had normal or subnormal haematocrit values and the remaining 17 were erythraemic. The mean value of erythropoietin (EPO) in both DIPF and COPD patients was significantly higher than normal. In conclusion, patients with DIPF exhibit a lack of erythropoietic response to hypoxaemia, despite the augmented erythropoietin levels. This may reflect a defective bone marrow erythropoietic response in DIPF patients. It is suggested that the pathophysiology of DIPF underlies this mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421504     DOI: 10.1053/rmed.2001.1070

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy.

Authors:  L Quan; B-L Zhu; T Ishikawa; T Michiue; D Zhao; D-R Li; M Ogawa; H Maeda
Journal:  Int J Legal Med       Date:  2008-08-06       Impact factor: 2.686

2.  Peripheral blood mononuclear cells show prominent gene expression by erythroid progenitors in diseases characterized by heightened erythropoiesis.

Authors:  Xu Zhang; Jihyun Song; Binal N Shah; Sergei Nekhai; Galina Miasnikova; Adelina Sergueeva; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

3.  The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Authors:  Suzanne M Cloonan; Sharon Mumby; Ian M Adcock; Augustine M K Choi; Kian Fan Chung; Gregory J Quinlan
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

4.  Polycythemia in dogs with chronic hypoxic pulmonary disease.

Authors:  Saila Holopainen; Henna P Laurila; Anu K Lappalainen; Minna M Rajamäki; Sanna J Viitanen
Journal:  J Vet Intern Med       Date:  2022-06-14       Impact factor: 3.175

5.  Changes in blood hemoglobin and blood gases PaO2 and PaCO2 in severe COPD overa three-year telemonitored program of long-term oxygen treatment.

Authors:  Roberto W Dal Negro; Silvia Tognella; Luca Bonadiman; Paola Turco
Journal:  Multidiscip Respir Med       Date:  2012-07-17

6.  The Relation of Erythropoietin Towards Hemoglobin and Hematocrit in Varying Degrees of Renal Insufficiency.

Authors:  Mirsad Panjeta; Ismet Tahirovic; Jasenko Karamehic; Emin Sofic; Ognjen Ridic; Jozo Coric
Journal:  Mater Sociomed       Date:  2015-06-08

7.  Anaemia and iron dysregulation: untapped therapeutic targets in chronic lung disease?

Authors:  Steven J Pascoe; Michael I Polkey; Mehul S Patel; Elizabeth McKie; Michael C Steiner
Journal:  BMJ Open Respir Res       Date:  2019-08-30

Review 8.  Iron and Sphingolipids as Common Players of (Mal)Adaptation to Hypoxia in Pulmonary Diseases.

Authors:  Sara Ottolenghi; Aida Zulueta; Anna Caretti
Journal:  Int J Mol Sci       Date:  2020-01-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.